Gossamer Bio, Inc.
GOSS
$2.40
-$0.06-2.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -71.60% | 70.31% | 68.56% | 61.77% | 60.90% |
| Total Depreciation and Amortization | -33.01% | -17.11% | -5.34% | -9.33% | -9.99% |
| Total Amortization of Deferred Charges | -23.05% | -18.07% | -17.79% | -9.90% | -1.35% |
| Total Other Non-Cash Items | -83.05% | -80.88% | -71.93% | -31.22% | -35.38% |
| Change in Net Operating Assets | -145.70% | 387.79% | 365.89% | 335.99% | 701.14% |
| Cash from Operations | -3,884.99% | 105.75% | 97.82% | 99.19% | 97.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 171.29% | 81.80% | 126.15% | 56.20% | -1,798.67% |
| Cash from Investing | 171.23% | 81.75% | 126.15% | 56.25% | -1,828.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 16.66% | -8.34% | -33.33% | -58.33% |
| Issuance of Common Stock | -99.56% | -99.61% | -99.69% | -99.69% | 64.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -99.52% | -104.43% | -106.04% | -107.57% | 65.75% |
| Foreign Exchange rate Adjustments | 1,653.85% | 370.83% | -192.73% | -60.87% | -105.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -221.44% | 62.69% | 117.49% | 23.60% | 187.02% |